BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi Biologics China PFS Site Clears FDA Inspection

WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...

July 22, 2025 | News

Fangzhou and Novo Nordisk Forge Strategic Alliance to Revolutionise Chronic Disease Management with AI

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, ...

July 21, 2025 | News

Concord Healthcare Delivers China’s First Proton Therapy for Choroidal Malignant Melanoma

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), whic...

July 15, 2025 | News

SCG Cell Therapy Secures China NMPA IND Approval for First Cell Therapy Targeting Chronic Hepatitis B

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announ...

July 08, 2025 | News

InnoCare Pharma Receives IND Approval in China for Novel B7-H3 Targeted ADC ICP-B794

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Inves...

July 07, 2025 | News

Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...

July 04, 2025 | News

Joincare Group Secures Greater China Rights to BRII-693 in Pact With Brii Biosciences

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to a...

July 04, 2025 | News

Thermo Fisher and CYDF Celebrate 10 Years of Inspiring Young Minds Across China Through Little Scientists Program

Thermo Fisher Scientific, the world leader in serving science, together with the China Youth Development Foundation (CYDF), proudly marked the 10th anniver...

July 03, 2025 | News

Dizal Secures FDA Approval for ZEGFROVY, the First Targeted Oral Therapy for EGFR Exon20ins NSCLC

ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20ins Approval follows the U....

July 03, 2025 | News

HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal

HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...

July 02, 2025 | News

WuXi Biologics Launches WuXiHigh™2.0 to Enable Record-Setting High-Concentration Biologic Formulations

The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces visc...

July 01, 2025 | News

EVA Pharma and Zhejiang Jinhua CONBA Forge Strategic Alliance to Reinforce Global Healthcare Supply Chains

Two Regional Powerhouses to Strengthen Cross-Border Collaboration for a More Resilient and Accessible Healthcare Supply Chain EVA Pharma, one of the leadi...

June 30, 2025 | News

Innovent Biologics Secures NMPA Approval for World’s First Dual GCG/GLP-1 Receptor Agonist Mazdutide for Weight Management in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

June 30, 2025 | News

Mabwell Grants Qilu Pharmaceutical Greater China Rights to Next-Generation Long-Acting G-CSF Albipagrastim Alfa

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an ag...

June 30, 2025 | News

Stay Connected